Comparison of Clinical Effects of Rituximab and Glatiramer Acetate in Secondary Progressive Multiple Sclerosis Patients
Clinical trial NCT03315923 · COMPLETED
Trial details
- NCT number
- NCT03315923
- Sponsor
- Isfahan University of Medical Sciences
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-01
- Primary completion
- 2019-02-01
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.